SERA PROGNOSTICS, INC. Repayments of Long-term Capital Lease Obligations
SERA PROGNOSTICS, INC. (SERA) reported Repayments of Long-term Capital Lease Obligations of $70.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermCapitalLeaseObligations · last filed 2022-03-29
- SERA PROGNOSTICS, INC. repayments of long-term capital lease obligations for the quarter ending 2021-12-31 was $19.00K, a 11.76% increase year-over-year.
- SERA PROGNOSTICS, INC. repayments of long-term capital lease obligations for the quarter ending 2021-09-30 was $17.00K, a 6.25% increase year-over-year.
- SERA PROGNOSTICS, INC. repayments of long-term capital lease obligations for the quarter ending 2020-12-31 was $17.00K.
- SERA PROGNOSTICS, INC. repayments of long-term capital lease obligations for the quarter ending 2020-09-30 was $16.00K.
- SERA PROGNOSTICS, INC. repayments of long-term capital lease obligations for fiscal 2021 was $70.00K, a 17.65% decline from fiscal 2020.
- SERA PROGNOSTICS, INC. repayments of long-term capital lease obligations for fiscal 2020 was $85.00K.
| Period end | Repayments of Long-term Capital Lease Obligations 3 month | Repayments of Long-term Capital Lease Obligations 6 month | Repayments of Long-term Capital Lease Obligations 9 month | Repayments of Long-term Capital Lease Obligations 12 month |
|---|---|---|---|---|
| 2021-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $36.00K derived: sum of 2 quarters · filed 2022-03-29 | $70.00K 10-K · filed 2022-03-29 | |
| 2021-09-30 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $51.00K 10-Q · filed 2021-11-09 | ||
| 2021-06-30 | $34.00K 10-Q · filed 2021-08-30 | |||
| 2020-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $33.00K derived: sum of 2 quarters · filed 2022-03-29 | $85.00K 10-K · filed 2022-03-29 | |
| 2020-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $68.00K 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $52.00K 10-Q · filed 2021-08-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |